BlackRock, Inc. (NYSE:BLK) today announced product enhancements to two iShares ETFs as part of an ongoing process to periodically review its product lineup. No action is necessary for investors in the impacted ETFs and no capital gains distributions are currently expected as a result of the transition. iShares Nasdaq Biotechnology ETF (IBB) Effective on or around June 21, 2021, the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) will seek to track the ICE Biotechnology Index. The fund will also undergo changes to its name and investment objective. Current New Fund Name iShares Nasdaq Biotechnology ETF iShares Biotechnology ETF Underlying Index Nasdaq Biotechnolo